Nan Fung Group Holdings LTD Travere Therapeutics, Inc. Transaction History

Nan Fung Group Holdings LTD

  • $103 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$18.47 - $26.14 $472,942 - $669,340
25,606 New
25,606 $538,000
Q1 2022

May 13, 2022
SELL
$23.61 - $30.6 $1.15 Million - $1.48 Million
-48,500 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$24.34 - $31.17 $1.18 Million - $1.51 Million
48,500 New
48,500 $1.51 Million

Others Institutions Holding TVTX

# of Institutions
198
Shares Held
84.9M
Call Options Held
776K
Put Options Held
912K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.3B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email